Diabetes mellitus (DM) is public health worldwide. Some 425 million people worldwide,
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - BMI 18.5-30 kg/m2 - Thai nationality - Diagnosis T2DM and fasting blood glucose lessthan 180 mg/dl - Concomitant therapy only stable oral hypoglycemic drugs such as metformin/Glucophage -Stable body weight for at least 6 mo
Exclusion criteria
Exclusion criteria: -Pregnant or lactating females -Persons with known allergies to any ingredients in either the active or placebo study compounds will be also excluded. -People who habitually used a dietary fiber supplement will be also excluded. -Following, or recently followed, a diet plan or supplement or medication use known to affect the trial - Persons with gastrointestinal disease, renal disease, liver disease, thyroid disease, concomitant therapy insulin, and also severe health condition (e.g., cancer, CVD) - participating in any vigorous exercise program
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fasting and postprandial glycemic response 2 days the automated (enzymatic) method | — |
Secondary
| Measure | Time frame |
|---|---|
| fasting and postprandial insulin response 2 days Chemiluminescence immunoassay (CLIA) | — |
Countries
Thailand
Contacts
Institute of Nutrition